WisdomTree U.S. SmallCap Earnings Fund ETF Implied Analyst Target Price of $63.32

The WisdomTree U.S. SmallCap Earnings Fund ETF (EES) has an implied analyst target price of $63.32 per unit, indicating 16.62% upside from its current trading price of $54.30. The underlying holdings with notable upside to their analyst target prices are OraSure Technologies, Sanara MedTech, and Asure Software. Analysts are optimistic about the future performance of these stocks, but further research is required to determine if the targets are justified.

Analysts have set an implied target price of $63.32 per unit for the WisdomTree U.S. SmallCap Earnings Fund ETF (EES), indicating a 16.62% upside from its current trading price of $54.30 [1]. The ETF's underlying holdings, particularly OraSure Technologies Inc (OSUR), Sanara MedTech Inc (SMTI), and Asure Software Inc (ASSU), are expected to drive this optimism. However, further research is required to determine if these targets are justified.

OraSure Technologies Inc, with a recent share price of $34.67, has an average analyst target price of $45.00, indicating a 24.6% upside [2]. Sanara MedTech Inc, trading at $24.80, has an average analyst price target of $49.00, representing a 94.4% upside [3]. Asure Software Inc, with a recent share price of $17.00, has an average analyst target price of $23.00, indicating a 35.3% upside [4].

Analysts have cited the companies' strategic pivots, operational turnarounds, and promising growth prospects as justifications for their high price targets. For instance, Sanara MedTech's surgical segment drove a 28% year-over-year revenue growth in Q2 2025, and the company has made significant strategic investments in AI wound care systems and term loan expansions [3]. OraSure Technologies has also shown strong growth potential, with analysts expecting a 24.8% increase in revenue [2]. Asure Software has been noted for its high-risk, high-reward potential, with analysts projecting a 35% annualized growth in revenue [4].

Despite these optimistic projections, investors should be cautious. The high price targets relative to the current trading prices could indicate overoptimism, or they might reflect a relic of the past if the targets were set before recent company and industry developments. Additionally, the companies' high-risk profiles, such as regulatory hurdles and market adoption challenges, should be considered.

In conclusion, while analysts see significant upside potential in the WisdomTree U.S. SmallCap Earnings Fund ETF and its underlying holdings, investors should conduct thorough research to assess the validity of these targets and consider the risks involved.

References:
[1] https://www.nasdaq.com/articles/how-pieces-add-rwj-headed-51
[2] https://finance.yahoo.com/news/david-nierenbergs-strategic-moves-cantaloupe-220035591.html
[3] https://www.ainvest.com/news/sanara-15min-chart-triggered-kdj-death-cross-bearish-marubozu-signal-2508/
[4] https://www.ainvest.com/news/sanara-medtech-strategic-pivots-operational-turnaround-signal-strong-investment-potential-2508/